ABCB1 p.His1195Tyr
Predicted by SNAP2: | A: N (61%), C: N (61%), D: N (53%), E: N (53%), F: N (53%), G: N (57%), I: N (57%), K: N (97%), L: N (53%), M: N (72%), N: N (72%), P: N (82%), Q: N (93%), R: N (87%), S: N (78%), T: N (72%), V: N (61%), W: D (53%), Y: N (53%), |
Predicted by PROVEAN: | A: N, C: D, D: N, E: N, F: D, G: N, I: D, K: N, L: N, M: N, N: N, P: N, Q: N, R: N, S: N, T: N, V: N, W: D, Y: N, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] A T3587G germ-line mutation of the MDR1 gene encod... Mol Cancer Ther. 2006 Apr;5(4):877-84. Mutoh K, Mitsuhashi J, Kimura Y, Tsukahara S, Ishikawa E, Sai K, Ozawa S, Sawada J, Ueda K, Katayama K, Sugimoto Y
A T3587G germ-line mutation of the MDR1 gene encodes a nonfunctional P-glycoprotein.
Mol Cancer Ther. 2006 Apr;5(4):877-84., [PMID:16648557]
Abstract [show]
The human multidrug resistance gene 1 (MDR1) encodes a plasma membrane P-glycoprotein (P-gp) that functions as an efflux pump for various structurally unrelated anticancer agents. We have identified two nonsynonymous germ-line mutations of the MDR1 gene, C3583T MDR1 and T3587G MDR1, in peripheral blood cell samples from Japanese cancer patients. Two patients carried the C3583T MDR1 allele that encodes H1195Y P-gp, whereas a further two carried T3587G MDR1 that encodes I1196S P-gp. Murine NIH3T3 cells were transfected with pCAL-MDR-IRES-ZEO constructs carrying either wild-type (WT), C3583T, or T3587G MDR1 cDNA and selected with zeocin. The resulting zeocin-resistant mixed populations of transfected cells were designated as 3T3/WT, 3T3/H1195Y, and 3T3/I1196S, respectively. The cell surface expression of I1196S P-gp in 3T3/I1196S cells could not be detected by fluorescence-activated cell sorting, although low expression of I1196S P-gp was found by Western blotting. H1195Y P-gp expression levels in 3T3/H1195Y cells were slightly lower than the corresponding WT P-gp levels in 3T3/WT cells. By immunoblotting analysis, both WT P-gp and H1195Y P-gp were detectable as a 145-kDa protein, whereas I1196S P-gp was visualized as a 140-kDa protein. 3T3/I1196S cells did not show any drug resistance unlike 3T3/H1195Y cells. Moreover, a vanadate-trap assay showed that the I1196S P-gp species lacks ATP-binding activity. Taken together, we conclude from these data that T3587G MDR1 expresses a nonfunctional P-gp and this is therefore the first description of such a germ-line mutation. We contend that the T3587G MDR1 mutation may affect the pharmacokinetics of MDR1-related anticancer agents in patients carrying this allele.
Comments [show]
None has been submitted yet.
No. Sentence Comment
3 Two patients carried the C3583T MDR1 allele that encodes H1195Y P-gp, whereas a further two carried T3587G MDR1 that encodes I1196S P-gp.
X
ABCB1 p.His1195Tyr 16648557:3:57
status: NEW5 The resulting zeocin-resistant mixed populations of transfected cells were designated as 3T3/WT, 3T3/H1195Y, and 3T3/I1196S, respectively. The cell surface expression of I1196S P-gp in 3T3/I1196S cells could not be detected by fluorescence-activated cell sorting, although low expression of I1196S P-gp was found by Western blotting.
X
ABCB1 p.His1195Tyr 16648557:5:101
status: NEW6 H1195Y P-gp expression levels in 3T3/H1195Y cells were slightly lower than the corresponding WT P-gp levels in 3T3/WT cells.
X
ABCB1 p.His1195Tyr 16648557:6:0
status: NEWX
ABCB1 p.His1195Tyr 16648557:6:37
status: NEW7 By immunoblotting analysis, both WT P-gp and H1195Y P-gp were detectable as a 145-kDa protein, whereas I1196S P-gp was visualized as a 140-kDa protein.
X
ABCB1 p.His1195Tyr 16648557:7:45
status: NEW8 3T3/I1196S cells did not show any drug resistance unlike 3T3/H1195Y cells.
X
ABCB1 p.His1195Tyr 16648557:8:61
status: NEW36 We were subsequently able to identify a novel germ-line mutation in the MDR1 gene, C3583T MDR1, which causes a substitution of tyrosine for His1195 in the P-gp (H1195Y P-gp).
X
ABCB1 p.His1195Tyr 16648557:36:127
status: NEWX
ABCB1 p.His1195Tyr 16648557:36:161
status: NEW37 In our current study, we have established T3587G MDR1 and C3583T MDR1 cDNA transfectants and examined both expression levels and functional properties of I1196S P-gp and H1195Y P-gp.
X
ABCB1 p.His1195Tyr 16648557:37:170
status: NEW48 The zeocin-resistant mixed populations of the transfected cells were designated as 3T3/WT, 3T3/H1195Y, and 3T3/I1196S, respectively.
X
ABCB1 p.His1195Tyr 16648557:48:95
status: NEW79 The C3583T MDR1 and T3587G MDR1 alleles encode H1195Y P-gp and I1196S P-gp, respectively, and both of the His1195 and Ile1196 residues are located in the Walker B region of the second ATP-binding site of P-gp (Fig. 1A).
X
ABCB1 p.His1195Tyr 16648557:79:47
status: NEW87 Arrows, location of the H1195Y and I1196S substitutions.
X
ABCB1 p.His1195Tyr 16648557:87:24
status: NEW91 April 2006 American Association for Cancer ResearchCopyright (c) 2006 on September 29, P-gp Expression Levels in the MDR1 Transfectants To investigate the molecular functions of the H1195Y mutant P-gp and I1196S mutant P-gp, we generated 3T3/ WT, 3T3/H1195Y, and 3T3/I1196S cells, which were stably transfected with WT MDR1, C3583T MDR1, and T3587G MDR1 cDNA, respectively. The P-gp expression levels on the cell surfaces of these transfectants were subsequently examined by FACS analysis using the MRK16 antibody, which recognizes a cell surface epitope of human P-gp.
X
ABCB1 p.His1195Tyr 16648557:91:183
status: NEWX
ABCB1 p.His1195Tyr 16648557:91:252
status: NEW92 Both 3T3/WT and 3T3/H1195Y cells express P-gp on their cell surface, although these expression levels in 3T3/ H1195Y cells (mean channel, 510) were slightly lower than in 3T3/WT cells (mean channel, 980; Fig. 2A).
X
ABCB1 p.His1195Tyr 16648557:92:20
status: NEWX
ABCB1 p.His1195Tyr 16648557:92:110
status: NEW96 Moreover, both WT P-gp and H1195Y P-gp were detectable as a 145-kDa protein, whereas I1196S P-gp was observed as a 140-kDa protein (Fig. 2B).
X
ABCB1 p.His1195Tyr 16648557:96:27
status: NEW106 As shown in Fig. 3, P-gp expression was observed in NIH3T3 cells transduced with both WT and H1195Y MDR1 retroviruses but not in cells transduced with I1196S MDR1 retrovirus.
X
ABCB1 p.His1195Tyr 16648557:106:93
status: NEW107 Transduction efficiencies were 70% and 60% for WT and H1195Y MDR1 retroviruses, respectively.
X
ABCB1 p.His1195Tyr 16648557:107:54
status: NEW108 P-gp expression in cells transduced with H1195Y MDR1 retrovirus was again found to be at a slightly lower levels than in cells transduced with WT MDR1 retrovirus (Fig. 3B and C).
X
ABCB1 p.His1195Tyr 16648557:108:41
status: NEW111 3T3/ H1195Y cells also showed higher levels of resistance to these drugs compared with the parental cells, but these were at slightly lower levels than 3T3/WT cells (Fig. 4).
X
ABCB1 p.His1195Tyr 16648557:111:5
status: NEW125 Loss of ATP-Binding Ability in I1196S P-gp Because H1195Y P-gp and I1196S P-gp have amino acid substitutions in the second ATP-binding site of P-gp, we examined the ATP-binding activities of these variants.
X
ABCB1 p.His1195Tyr 16648557:125:51
status: NEW128 Because 3T3/I1196S clone 23 expressed f25% of the WT P-gp levels, and 3T3/H1195Y cells expressed f50% of the WT levels, we normalized these amounts in the relevant experiments (Fig. 5B and C).
X
ABCB1 p.His1195Tyr 16648557:128:74
status: NEW130 However, verapamil stimulated the nucleotide trapping of both WT P-gp and H1195Y P-gp, both of which showed similar levels of ATP-binding activity (Fig. 5C and D).
X
ABCB1 p.His1195Tyr 16648557:130:74
status: NEW150 C, NIH3T3 cells transduced with H1195Y MDR1 retrovirus.
X
ABCB1 p.His1195Tyr 16648557:150:32
status: NEW155 ), 3T3/WT (o), 3T3/H1195Y (4), and 3T3/I1196S (w ) cells were cultured for 5 d with various concentrations of vincristine or doxorubicin. Cell numbers were determined using a cell counter.
X
ABCB1 p.His1195Tyr 16648557:155:19
status: NEW174 As shown in Fig. 2A, most of the 3T3/WT and 3T3/H1195Y cells expressed cell surface P-gp.
X
ABCB1 p.His1195Tyr 16648557:174:48
status: NEW176 To confirm our finding of a lower expression level of H1195Y P-gp, we did retrovirus-mediated gene transfer.
X
ABCB1 p.His1195Tyr 16648557:176:54
status: NEW177 Cells transduced with H1195Y MDR1 retrovirus showed slightly lower P-gp expression levels than those transduced with WT MDR1 retrovirus (Fig. 3).
X
ABCB1 p.His1195Tyr 16648557:177:22
status: NEW178 We therefore speculate that the difference in P-gp expression between 3T3/WT and 3T3/H1195Y cells is genuine and can be attributed to post-transcriptional events, such as protein maturation and/or stability.
X
ABCB1 p.His1195Tyr 16648557:178:85
status: NEW185 C, ATP-binding activity of H1195Y P-gp. Plasma membrane protein extracts of NIH3T3 (20 Ag), 3T3/WT (10 Ag), and 3T3/H1195Y (20 Ag) cells were analyzed as in B. Top, autoradiography using a radioimaging analyzer; bottom, Western blotting analysis of the same blot with the anti-P-gp antibody C219. Arrows, P-gps.
X
ABCB1 p.His1195Tyr 16648557:185:27
status: NEWX
ABCB1 p.His1195Tyr 16648557:185:116
status: NEW200 Our present study also shows that substitution of serine for Ile1196 results in the loss of ATP-binding activity but that the substitution of tyrosine for His1195 does not affect P-gp function.
X
ABCB1 p.His1195Tyr 16648557:200:142
status: NEW